Clinical outcomes in the neoadjuvant cisplatin and paclitaxel for bulky stage II cervical squamous cell carcinoma.
Radical surgery after neoadjuvant chemotherapy for bulky stage II cervical squamous cell carcinoma confirmed to prolong DFS.
The largest case series of the patients with stage bulky stage II cervical cancer subjected to this therapeutic strategy.